On the morning of February 16, Li Yaohua, director of the Yangtze River Delta Branch Center for Medical Device Technology Evaluation and Inspection of the State Drug Administration (hereinafter referred to as the Yangtze River Delta Branch Center), and his party visited Fuqing Medical for research and guidance. Zhang Lei, relevant leaders of the Licensing and Registration Office and the Drug Evaluation and Inspection Center accompanied the investigation. Professor Long Chaoyang, Chief Strategy Officer of Fuqing Medical, and relevant leaders of the company warmly received the visit.

The research team mainly learned about the transformation of Fuqing Medical's scientific research achievements, R&D progress, product launch, etc., listened to Fuqing Medical's needs for device declaration and registration, and gave responses and guidance on related demands.

The research team understands the business sector of Fuqing Medical

At the symposium, Director Li Yaohua introduced the consultation and communication mechanism of the Yangtze River Delta Branch Center, and encouraged enterprises to actively communicate and be good at communication. He said that the Yangtze River Delta Branch Center is committed to building a practice platform to promote the high-quality integrated development of the Yangtze River Delta region, a cooperation platform to deepen the reform of the drug and medical device review and approval system, and an incubation platform to serve the innovation and development of the pharmaceutical industry. The drug regulatory department promotes the rapid development of the medical device industry in the Yangtze River Delta region.

Director Li Yaohua pointed out that the transformation and implementation of scientific research achievements is a long process. During this period, the quality control system must be simultaneously improved, and product quality standards must be strictly controlled. Contribute to high-quality development.

Deputy Director Zhang Lei said that Fuqing Medical is a vigorous high-tech enterprise, backed by the academic platform of HKUST, and has a unique talent advantage. It is necessary to firmly grasp this core competitive advantage and speed up the transformation of scientific research results. Actively report problems encountered during the transformation process. For high-quality scientific research results, various departments will try their best to provide solutions, and work together to accelerate scientific research results from the laboratory to clinical application.

The two sides of the symposium started exchanges

Professor Long Chaoyang welcomed and thanked the research team of the Yangtze River Delta Sub-center for this visit. He said that in the future, Fuqing Medical will communicate with various departments of the Yangtze River Delta Sub-center with a more positive attitude, hoping that the Yangtze River Delta Sub-center can provide support in the follow-up technical review of medical devices, consultation on issues before registration and acceptance, and declaration of innovative medical devices. support and help.